BPC 157: The peptide with big claims and scant evidence STAT In a major policy shift, the U.S. Food and Drug Administration is reconsidering restrictions on several controversial peptides, including trending compounds like BPC 157 and Melanotan II. The move comes as demand for RFK Jr. and the Perils of Peptides Washington Monthly The Human Lab Rats Injecting Themselves with Peptides Office for Science and Society McGill University The trend of unproven peptides is spreading through influencers and RFK Jr. allies CNN